Mutant ACTB mRNA 3'-UTR promotes hepatocellular carcinoma development by regulating miR-1 and miR-29a
Yong Li1, Hongbin Ma1, Changying Shi2
1Department of Radiation Oncology, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Abstract:
In recent years, studies demonstrate that ACTB has been found to be associated with various tumors. Although ACTB is dysregulated in numerous cancer types, limited data are available on the potential function and mechanism of ACTB in hepatocellular carcinoma (HCC). This study evaluated the expression and biological roles of mutant ACTB mRNA 3'-UTR in HCC. Transcriptome sequence and qRT-PCR analysis determined that mutant ACTB mRNA '-UTR was high expression in tumor tissues. Luciferase reporter assay showed that the ACTB mRNA 3'-UTR mutations made it easier to interact with miR-1 and miR-29a. Moreover, mutant ACTB mRNA '-UTR regulated miR-1 and miR-29a degradation via AGO2. Furthermore, mutant ACTB mRNA 3'-UTR promoted hepatocellular carcinoma cells migration and invasion in vitro and in vivo by up-regulating miR-1 target gene MET and miR-29a target gene MCL1. In a word, our study demonstrates that 3'-UTR of ACTB plays a key role in the development of hepatocellular carcinoma (HCC) and highlights the molecular mechanisms underlying such a complex process.
Insights
Mutant ACTB mRNA 3'-UTR promotes hepatocellular carcinoma (HCC) development by interacting with miR-1 and miR-29a. This interaction up-regulates MET and MCL1, driving cancer cell migration and invasion.
Area of Science:
- Molecular Biology
- Oncology
- Hepatocellular Carcinoma Research
Background:
- Actin beta (ACTB) is implicated in various cancers, but its specific role in hepatocellular carcinoma (HCC) remains unclear.
- Limited research exists on the function and mechanisms of ACTB, particularly its mutant mRNA 3 -untranslated region (UTR), in HCC development.
Purpose of the Study:
- To investigate the expression and biological functions of mutant ACTB mRNA 3 -UTR in hepatocellular carcinoma (HCC).
- To elucidate the molecular mechanisms by which mutant ACTB mRNA 3 -UTR influences HCC progression.
Main Methods:
- Transcriptome sequencing and quantitative reverse transcription PCR (qRT-PCR) to analyze ACTB expression.
- Luciferase reporter assays to assess interactions between ACTB mRNA 3 -UTR and microRNAs (miRNAs).
- In vitro and in vivo assays to evaluate the impact of mutant ACTB mRNA 3 -UTR on HCC cell behavior.
Main Results:
- Mutant ACTB mRNA 3 -UTR exhibited high expression in HCC tumor tissues.
- ACTB mRNA 3 -UTR mutations facilitated interactions with miR-1 and miR-29a, leading to their degradation via AGO2.
- Mutant ACTB mRNA 3 -UTR promoted HCC cell migration and invasion by up-regulating MET (miR-1 target) and MCL1 (miR-29a target).
Conclusions:
- The 3 -UTR of ACTB plays a critical role in the pathogenesis of hepatocellular carcinoma (HCC).
- Mutant ACTB mRNA 3 -UTR contributes to HCC development through a mechanism involving miR-1, miR-29a, MET, and MCL1.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...


